RxDoctor Payments Data

Amy Keenan, PA

Physician Assistant · Maryville, TNNPI 1528523719

Payments from drug & device makers

$342in general payments, 2019–2025

Across 22 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$84
  • Boehringer Ingelheim$49
  • AbbVie$41
  • Pfizer$38
  • Novo Nordisk$30
  • Amarin Pharma, Inc.$18
  • plus $82 from 6 others

What the payments were for

  • Food & beverage$342100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$342 in reported general payments places this provider in the 50th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$55,753
Medicare patients
238
Services billed
1,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban188$112,480
JardianceEmpagliflozin107$69,403
XareltoRivaroxaban64$42,984
TrulicityDulaglutide38$39,129
Breo ElliptaFluticasone/Vilanterol38$15,863
BrilintaTicagrelor34$15,668
JanuviaSitagliptin Phosphate22$13,524
VeltassaPatiromer Calcium Sorbitex11$13,294
Stiolto RespimatTiotropium Br/Olodaterol Hcl17$8,803
Quetiapine Fumarate471$8,273
MyrbetriqMirabegron18$8,176
Atorvastatin Calcium649$7,789
CreonLipase/Protease/Amylase17$7,431
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$7,090
Potassium Chloride308$6,332

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$38$112,480188 claims
Boehringer IngelheimJardiance, Stiolto Respimat$49$78,206124 claims
Lilly USA, LLCTrulicity$15$39,12938 claims
GSKBreo Ellipta, Arnuity Ellipta, Anoro Ellipta$17$27,21675 claims
AbbVieCreon$41$7,43117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Maryville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →